Longterm treatment

Long-term therapy, consisting of oral calcium and vitamin D, is indicated in most cases of hypocalcemia. The goal of long-term treatment is maintenance of serum calcium in the low-normal range. This alleviates hypocalcemic symptoms, while avoiding hypercalciuria, and provides a cushion against treatment-induced hypercalcemia. Oral elemental calcium 1 to 3 g/day in divided doses is usually sufficient. Several pharmacological preparations of calcium are available. Calcium citrate is more soluble than calcium carbonate, particularly in patients taking H 2 antagonists or proton-pump inhibitors and those with achlorhydria.

The principal effect of vitamin D is to increase gut calcium absorption, although it also has an effect on bone resorption. Various forms of vitamin D may be used depending on the specific abnormality of vitamin D synthesis. Vitamin D2 (ergocalciferol—the parent compound) requires hepatic and renal transformation for full activation. For most cases of hypocalcemia, usually hypoparathyroidism, vitamin D3 (cholecalciferol) is sufficient. 25-Hydroxyvitamin D (calcifediol—the product formed by hepatic conversion of vitamin D) may be used in severe liver disease, and 1,25-dihydroxyvitamin D (calcitriol—the active metabolite formed in the kidney) is most appropriate in vitamin D resistance, severe renal impairment, and patients with hypoparathyroidism unresponsive to other forms of vitamin D therapy. Vitamin D requirements may vary based on disease activity, interacting drugs, and dietary calcium intake. Hypercalciuria may occur during treatment. In this situation, a thiazide diuretic can be helpful in reducing urinary calcium excretion.

Was this article helpful?

0 0
Sleep Apnea

Sleep Apnea

Have You Been Told Over And Over Again That You Snore A Lot, But You Choose To Ignore It? Have you been experiencing lack of sleep at night and find yourself waking up in the wee hours of the morning to find yourself gasping for air?

Get My Free Ebook


Post a comment